Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • War Day 191: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 191: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • BrandRep Launches Innovative Social Media Campaigns to Revolutionize Local Marketing
    BrandRep Launches Innovative Social Media Campaigns to Revolutionize Local Marketing World News
  • Professional Development of Leadership Roles of Latino Managers in Corporate America
    Professional Development of Leadership Roles of Latino Managers in Corporate America Business
  • One-Year Anniversary of the Terrorist Attack on the UAE
    One-Year Anniversary of the Terrorist Attack on the UAE World News
  • Russia begins civilian evacuation from Kherson – BBC News
    Russia begins civilian evacuation from Kherson – BBC News World News
  • Procom Announces Successful AI Integration in Talent Acquisition
    Procom Announces Successful AI Integration in Talent Acquisition World News
  • Release of the 2021 Country Reports on Terrorism
    Release of the 2021 Country Reports on Terrorism World News
  • geniant, a Next Generation Consulting Firm Shaping Today’s Experiences, Announces New President, Andrew Balster
    geniant, a Next Generation Consulting Firm Shaping Today’s Experiences, Announces New President, Andrew Balster Business
DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

Posted on May 12, 2024 By NewsEditor

VANCOUVER, BC, CANADA, May 1, 2024 /EINPresswire.com/ — DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Utilise its Proprietary AI Engine to Evaluate and Co-Develop Novel Vaccines Addressing Unmet Needs in the Veterinary Market

Vancouver, British Columbia–(EIN Presswire. – May 1, 2024) – DiaGen AI Inc. (“DiaGen” or the “Company”) founded in 2021 to advance its proprietary Artificial Intelligence (“AI”) engine in protein design, drug discovery and diagnostics for health, wellness, longevity, and precision medicine is pleased to announce it has signed a Technology Evaluation Agreement (“TEA”) with Cambridge, UK based The Vaccine Group (“TVG”) to advance its novel veterinary vaccine pipeline.

“The Partnership with DiaGen will bring strong complimentary AI approaches to develop novel and improved vaccines. TVG’s herpesviral vector delivery system will be used to deliver transgenes designed for expression of optimal antigenic proteins in animal patients. Initial focus will be on the development of broadly protective vaccine candidates for a disease caused by a highly variable virus. This new partnership with DiaGen represents a significant development in TVG’s ability to address key gaps in the veterinary vaccine market,” said Jeremy Salt, TVG CEO.

“We are excited to further iterate our proprietary Ai capabilities into a new addressable market in the Veterinary sector to optimize the ideal protein structures for expression and immune stimulation to complement TVG’s experienced team in advancing their vaccine pipeline,” said Paolo Lobo, DiaGen’s President.

Both DiaGen and TVG are portfolio companies of publicly traded Frontier IP Group PLC (LON:FIPP) who introduced the parties to advance their collaboration and partnership.

For more information about DiaGen Ai Inc., please visit www.diagen.ai

Or

Contact us:

Brian D. Keane, Chairman and CEO Email: [email protected]

For more information about The Vaccine Group Ltd., please visit www.thevaccinegroup.com

Or

Contact

Jeremy Salt, CEO Email: [email protected]

Forward-Looking Statement Cautions

This press release contains certain “forward-looking statements” within the meaning of Canadian securities legislation, relating to the Company’s plans and expectations. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words “expects,” “plans,” “anticipates, ” “believes,” “intends, ” “estimates,” “projects,” “aims,” “suggests,” “indicate,” “often,” “target,” “future,” “likely,” “pending,” “potential,” “goal,” “objective, ” “prospective, ” and “possibly,” and similar expressions, or that events or conditions “will,” “would,” “may,” “can,” “could” or “should” occur, or are those statements, which, by their nature, refer to future events. Forward-looking statements in this news release include statements relating to: the Company’s ability to make advancements in industry using its proprietary DIA technology; the Company’s focus on the AI sector; the Company providing a return on investment for its shareholders; and the continued growth of the Company, viability of its DIA technology; general applicability of AI technology towards the healthcare sector, particularly drug discovery, diagnostics, and vaccines; the ability of the Company to find strategic acquisitions and consummate transactions to acquire such entities; and the ability of the Company to use its technology to make a meaningful impact on the healthcare industry.

The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Except to the extent required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors, should change. Factors that could cause future results to differ materially from those anticipated in these forward-looking statements that the Company will not be able to raise sufficient funds to carry out its business plans, and the risk of political uncertainties and regulatory or legal changes that might interfere with the Company’s business and prospects.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company’s ability to make advancements in industry using its proprietary DIA technology; the Company’s expectation of growth of the AI sector as it applies to healthcare; the Company’s ability to provide a return on investment for its shareholders; the continued growth of the Company; the viability of the Company’s DIA technology; the continued applicability of AI technology within the healthcare sector, particularly drug discovery, diagnostics, and vaccines; the ability of the Company to find strategic acquisitions and consummate transactions to acquire such entities; and the ability of the Company to use its technology to make a meaningful impact on the healthcare industry.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward- looking information, except as required by applicable law.

Brian Keane
Diagen AI Inc
+1 201-736-3590
[email protected]
Visit us on social media:
Twitter
LinkedIn
Instagram

DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

You just read:

News Provided By

May 01, 2024, 14:00 GMT

Distribution channels:
Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry, Companies, Consumer Goods, Healthcare & Pharmaceuticals Industry, Media, Advertising & PR, Science, Social Media, Technology, World & Regional
…


EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.



Article originally published on www.einpresswire.com as DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

World News

Post navigation

Previous Post: ESET Announces Integration with Arctic Wolf to Deliver Next-Gen Detection and Response for Businesses
Next Post: Dream Quest Foundation takes center stage

Related Posts

  • War Day 30 :: conversations with @Alexey Arestovych
    War Day 30 :: conversations with @Alexey Arestovych World News
  • Maple Syrup Market Size, Share, Revenue, Trends And Drivers For 2023-2032
    Maple Syrup Market Size, Share, Revenue, Trends And Drivers For 2023-2032 World News
  • CCWC Launches Launches Exclusive Salary Negotiation Master Class to Help Job Seekers Unlock Their Earning Potential
    CCWC Launches Launches Exclusive Salary Negotiation Master Class to Help Job Seekers Unlock Their Earning Potential World News
  • New Saja Makkah Hotel Elevates Pilgrim Hospitality Experience
    New Saja Makkah Hotel Elevates Pilgrim Hospitality Experience World News
  • New Motivational Series by Tracy Emerick Explores the Divine Connection in Everyday Heroes
    New Motivational Series by Tracy Emerick Explores the Divine Connection in Everyday Heroes World News
  • ‘Listen To This Beat And Relax’ With Quan Aqua Faust’s New Song, “Got Me Like”
    ‘Listen To This Beat And Relax’ With Quan Aqua Faust’s New Song, “Got Me Like” World News
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Sécuriser vos recrutements en France grâce aux Background Checks structurésAugust 10, 2025
  • Creative Canvas Named Top Iowa Web Design Agency in 2025 Small Business AwardsAugust 10, 2025
  • A Courageous Memoir of Illness, Advocacy, and the Power of Human ConnectionAugust 10, 2025
  • Tethered Drone Market Growing at 4.9% CAGR to Generate $404.9 Million by 2031August 9, 2025
  • How She Bought a Business for $2,500 and Helps Others Do the SameAugust 9, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Thank You Manjeri for the Warm Welcome to the Marathon Runners, Says Sabeer Nelli
    Thank You Manjeri for the Warm Welcome to the Marathon Runners, Says Sabeer Nelli World News
  • War Day 657: West is Bankrupt. Ukraine in the Funnel of Catastrophe.
    War Day 657: West is Bankrupt. Ukraine in the Funnel of Catastrophe. World News
  • War Day 167: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych  & #Feygin
    War Day 167: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety
    STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety Business
  • Under Secretary of State for Political Affairs Nuland’s travel to Nepal, India, Sri Lanka, and Qatar
    Under Secretary of State for Political Affairs Nuland’s travel to Nepal, India, Sri Lanka, and Qatar World News
  • War Day 118: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych  & #Feygin
    War Day 118: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • Buildremote Unveils The Top 25 US Cities For Company Retreats
    Buildremote Unveils The Top 25 US Cities For Company Retreats Business
  • War Day 335: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 335: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .